{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:05:57Z","timestamp":1781953557177,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ygyno.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T18:18:41Z","timestamp":1710526721000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer"],"prefix":"10.1016","volume":"183","author":[{"given":"Dylan H.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayeromi","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Mysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Potkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Roeske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Harkenrider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ygyno.2024.03.003_bb0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National cancer data base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ygyno.2024.03.003_bb0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijrobp.2019.10.042","article-title":"A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer","volume":"106","author":"Albuquerque","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2024.03.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1259\/0007-1285-11-132-809","article-title":"A dosage system for use in the treatment of cancer of the uterine cervix","author":"Tod","year":"1938","journal-title":"Br. J. Radiol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.03.003_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.radonc.2012.04.007","article-title":"Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study","volume":"103","author":"Charra-Brunaud","year":"2012","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.03.003_bb0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijrobp.2006.12.021","article-title":"Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours","volume":"68","author":"Viswanathan","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ygyno.2024.03.003_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2024.03.003_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3109\/0284186X.2013.818253","article-title":"MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective","volume":"52","author":"Lindegaard","year":"2013","journal-title":"Acta Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.03.003_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2014.08.027","article-title":"Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy","volume":"135","author":"Rijkmans","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.03.003_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","article-title":"Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer","volume":"100","author":"P\u00f6tter","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.03.003_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2013.04.006","article-title":"Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience","volume":"107","author":"Nomden","year":"2013","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.03.003_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brachy.2017.09.010","article-title":"Early outcomes and impact of a hybrid IC\/IS applicator for a new MRI-based cervical brachytherapy program","volume":"17","author":"Harkenrider","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2024.03.003_bb0065","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03","author":"National Institutes of Health and National Cancer Institute","year":"2010"},{"issue":"2","key":"10.1016\/j.ygyno.2024.03.003_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5114\/jcb.2017.66892","article-title":"How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer","volume":"9","author":"Harkenrider","year":"2017","journal-title":"J. Contemp. Brachyther."},{"issue":"3","key":"10.1016\/j.ygyno.2024.03.003_bb0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.03.003_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American brachytherapy society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ygyno.2024.03.003_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.ygyno.2024.03.003_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.03.003_bb0095","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijrobp.2014.10.053","article-title":"MRI-guided high\u2013dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience","volume":"91","author":"Gill","year":"2015","journal-title":"Int. J. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.03.003_bb0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.radonc.2010.10.002","article-title":"3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control","volume":"97","author":"Kang","year":"2010","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.03.003_bb0105","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ijrobp.2015.04.018","article-title":"Inverse planned high-dose-rate brachytherapy for locoregionally advanced cervical cancer: 4-year outcomes","volume":"92","author":"Tinkle","year":"2015","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2024.03.003_bb0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2021.01.019","article-title":"Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: an EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.03.003_bb0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose\u2013volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.03.003_bb0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2015.06.027","article-title":"Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: dose\u2013volume effect relationships for the rectum and bladder","volume":"116","author":"Mazeron","year":"2015","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.03.003_bb0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijrobp.2010.12.029","article-title":"Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy","volume":"82","author":"Georg","year":"2012","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2024.03.003_bb0130","article-title":"3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes - ClinicalKey","volume":"no. 4","author":"Kharofa","year":"2014","journal-title":"Brachytherapy"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:07:11Z","timestamp":1717499231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":26,"alternative-id":["S0090825824001422"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}